• Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial 

      Rahhal, Alaa; Najim, Mostafa; Aljundi, Amer Hussein; Mahfouz, Ahmed; Alyafei, Sumaya Mehdar; ... more authors ( Lippincott Williams and Wilkins , 2022 , Article)
      Introduction: Colchicine acts upstream in the cytokines cascade by inhibiting the nod-like receptor protein 3 (NLRP3) inflammasome while interleukin 6 (IL-6) receptor antagonists, such as tocilizumab, block the end result ...
    • Critical care tele-pharmacy services during COVID-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions 

      Isleem, Nour; Shoshaa, Sadim; AbuGhalyoun, Ahmad; Khatib, Mohamad; Naseralallah, Lina Mohammad; ... more authors ( Wiley-Blackwell , 2022 , Article)
      What is Known and Objective: The scope of clinical pharmacy services has changed during COVID-19 pandemic with the view to mitigating both exposure and spread of the virus. The performance of novel pandemic-driven services ...
    • Early predictors of intensive care unit admission among COVID-19 patients in Qatar 

      Abuyousef, Safae; Alnaimi, Shaikha; Omar, Nabil E.; Elajez, Reem; Elmekaty, Eman; ... more authors ( Frontiers Media SA , 2024 , Article)
      Background: COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19. Methods: This was a ...